HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news release. The negotiations,
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
Government picks 15 more prescription drugs for Medicare price negotiation
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has selected 15 additional drugs for pr
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices that go into effect in 2027.
Trump Reverses Some Biden Drug Pricing Initiatives, Potentially Impacting Medicare Costs
Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.
Trump rolls back effort to lower Medicare, Medicaid drug costs
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Trump cancels Biden’s rule to help Medicare lower prescription drug prices
Drug pricing experts are not sure why rolling back drug pricing initiatives would be a day one priority for President Trump.
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.
STAT8d
Former Trump White House, HHS aide Abe Sutton likely to lead Medicare, Medicaid innovation center
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
McKnight's Long-Term Care News8h
Speculation, concern continue as details on federal health communications pause emerge
Federal health agencies, including CMS, have halted almost all external communication as part of the presidential transition.
KERA News13h
Federal health agencies told to halt all external communications
In a memo obtained by NPR, acting Health Secretary Dorothy Fink forbade staff from public communications on most matters ...
Medicare’s 2025 Drug Negotiation List Includes Ozempic and Wegovy
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
Modern Healthcare1d
Trump freezes HHS communications
The Health and Human Services Department won’t issue health advisories, reports or other materials until further notice, the ...
Skilled Nursing News15h
Legal Defeat Remains Key Even if Legislative, Administrative Barriers Make Repeal of the Nursing Home Staffing Mandate Inevitable
In the aftermath of the Department of Health and Human Services’ (HHS) response to a pending lawsuit against the federal ...
Departed Biden Medicare Chief Lauds Landmark Drug Negotiations
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
CMS Doubles Down on Medicare Drug Price Controls, Threatening Patient Access and Innovation
ARLINGTON, VIRGINIA / ACCESS Newswire / January 22, 2025 / The Centers for Medicare & Medicaid Services (CMS) has announced ...